Evidence map›Paper›PMID 30392575›Full record

Trial reportProstaglandins, leukotrienes, and essential fatty acids2018

Dose-response relationship between docosahexaenoic acid (DHA) intake and lower rates of early preterm birth, low birth weight and very low birth weight.

Susan E Carlson, Byron J Gajewski, Sibelle Alhayek, John Colombo, Elizabeth H Kerling, Kathleen M Gustafson

Open access · greenAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Prostaglandins, leukotrienes, and essential fatty acids, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Omega-3 fatty acid addition during pregnancy.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Susan E CarlsonDepartment of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: scarlson@kumc.edu.
Byron J GajewskiDepartment of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA.
Sibelle AlhayekDepartment of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA.
John ColomboSchiefelbusch Institute for Life Span Studies/Department of Psychology, University of Kansas, Lawrence, KS, USA.
Elizabeth H KerlingDepartment of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA.
Kathleen M GustafsonDepartment Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
University of Kansas Medical Center · USUniversity of Kansas · US

Funding

DHA Supplementation and Pregnancy OutcomeR01HD047315 · NICHD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CARLSON, SUSAN E, COLOMBO, JOHN A. · 2006 to 2016
$4.9M
NICHD NIH HHS R01 HD047315
6 · The paper itself

Abstract

As previously reported, intention-to-treat findings from our phase III randomized clinical trial found that a supplement of 600 mg docosahexaenoic acid (DHA)/day during the last half of pregnancy reduced the incidence of early preterm birth (ePTB, <34 weeks gestation) and very low birth weight (VLBW < 1500 g) offspring. Given the potentially immense clinical significance of these findings, the goal of this secondary analysis was to (1) identify maternal characteristics related with capsule intake (i.e. DHA dose exposure) and (2) determine if DHA dose was associated with low (<2500 g) and very low birth weight after controlling for any relevant maternal characteristics. Three hundred forty-five pregnant mothers were recruited from hospitals in the Kansas City metropolitan area between 2006 and 2011. Most participants (n = 299) were from the phase III trial mentioned above, but we also included 46 participants from a second smaller, randomized trial that utilized an identical intervention design and was conducted concurrent to the larger trial. Both trials assigned participants to either 3 daily capsules of vegetable oil without DHA (n = 169) or 3 daily capsules of 200 mg DHA each (n = 176). Total capsules consumed was recorded by pharmacy supervised capsule count or participant self-report when needed. Maternal age, education, race and gestational age at delivery as well as infant birth weight were available for both trials. A Bayesian linear model indicated capsule intake increased with maternal age (p = 0.0100) and years of education (p = 0.0002). A Bayesian bivariate mixture-model associated capsule intake with simultaneous lower probability of ePTB, low birth weight (LBW, <2500 g) and VLBW (p = 0.0327). This, in conjunction with the positive findings in the clinical trial, support the need for future research to examine intervention methods to improve capsule compliance strategies in younger and less educated mothers.

Indexed as

Dietary SupplementsInfant, Very Low Birth WeightAdultDocosahexaenoic AcidsDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansInfant, NewbornPregnancyPremature BirthDocosahexaenoic AcidsBirth weightComplianceDocosahexaenoic acidPlaceboPreterm birth

Identifiers

PMID30392575
PMCPMC9837789
OpenAlexW2890803933

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.